Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 24 October 2000
Vol. 2000, Issue 55, p. tw2
[DOI: 10.1126/stke.2000.55.tw2]

EDITORS' CHOICE

Cancer biology Protease Frees VEGF for Angiogenic Action

To become invasive (and thus really nasty), tumor cells need cooperation from other cells, particularly vascular endothelial cells that form new blood vessels in the tissues that the cancer cells invade. Bergers et al. used a transgenic mouse model of multistage carcinogenesis (RIP1-Tag2 mice expressing the SV40 T antigen) to analyze the onset of angiogenesis during development of tumors of the pancreatic islets. They unexpectedly found that vascular endothelial growth factor (VEGF)--an established inducer of angiogenesis--and its receptors were constitutively expressed in islets and did not increase in abundance when angiogenesis began. Nevertheless, an inhibitor of VEGF signaling did inhibit angiogenesis and tumor growth. What did correlate with angiogenesis was expression of matrix metalloproteinase-9. Furthermore, expression of MMP-9 promoted angiogenesis and release of VEGF from cultured islets. MMP-9 is not the whole story, however, because angiogenesis could still be observed when MMP-9 was absent or inhibited. Nevertheless, MMP-9 clearly participates in the "angiogenic switch" that leads to formation of pancreatic tumors in this model system. The results pose some new puzzles as well: MMP-9 appears not to be expressed by the cancer cells themselves, so what is the nature of the rare cells that appear to supply the enzyme and resemble infiltrating inflammatory cells? And what might the mechanism be by which VEGF is sequestered such that MMP-9 and other mechanisms can control its release and subsequent activity?

Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2: 737-744. [Online Journal]

Citation: Protease Frees VEGF for Angiogenic Action. Sci. STKE 2000, tw2 (2000).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882